|Inflammation and cancer: how hot is the link?|
BB Aggarwal, S Shishodia, SK Sandur, MK Pandey, G Sethi
Biochemical pharmacology 72 (11), 1605-1621, 2006
|The vascular endothelium and human diseases|
P Rajendran, T Rengarajan, J Thangavel, Y Nishigaki, D Sakthisekaran, ...
International journal of biological sciences 9 (10), 1057, 2013
|Curcumin: getting back to the roots|
S Shishodia, G Sethi, BB Aggarwal
Annals of the New York Academy of sciences 1056 (1), 206-217, 2005
|Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS …|
SK Sandur, MK Pandey, B Sung, KS Ahn, A Murakami, G Sethi, ...
Carcinogenesis 28 (8), 1765-1773, 2007
|Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors|
KS Siveen, S Sikka, R Surana, X Dai, J Zhang, AP Kumar, BKH Tan, ...
Biochimica et Biophysica Acta (BBA)-reviews on cancer 1845 (2), 136-154, 2014
|Thymoquinone: potential cure for inflammatory disorders and cancer|
CC Woo, AP Kumar, G Sethi, KHB Tan
Biochemical pharmacology 83 (4), 443-451, 2012
|Nuclear factor-κB activation: from bench to bedside|
G Sethi, B Sung, BB Aggarwal
Experimental biology and medicine 233 (1), 21-31, 2008
|Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements|
V Aggarwal, HS Tuli, A Varol, F Thakral, MB Yerer, K Sak, M Varol, A Jain, ...
Biomolecules 9 (11), 735, 2019
|Targeting signal‐transducer‐and‐activator‐of‐transcription‐3 for prevention and therapy of cancer: modern target but ancient solution|
BB Aggarwal, G Sethi, KS Ahn, SK Sandur, MK Pandey, ...
Annals of the New York Academy of Sciences 1091 (1), 151-169, 2006
|TNF: a master switch for inflammation to cancer|
G Sethi, B Sung, BB Aggarwal
Frontiers in Bioscience-Landmark 13 (13), 5094-5107, 2008
|The E-cadherin and N-cadherin switch in epithelial-to-mesenchymal transition: signaling, therapeutic implications, and challenges|
CY Loh, JY Chai, TF Tang, WF Wong, G Sethi, MK Shanmugam, ...
Cells 8 (10), 1118, 2019
|Targeting transcription factor NF-κB to overcome chemoresistance and radioresistance in cancer therapy|
F Li, G Sethi
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1805 (2), 167-180, 2010
|The role of resveratrol in cancer therapy|
JH Ko, G Sethi, JY Um, MK Shanmugam, F Arfuso, AP Kumar, A Bishayee, ...
International journal of molecular sciences 18 (12), 2589, 2017
|Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-κB–regulated antiapoptotic and cell …|
A Bhardwaj, G Sethi, S Vadhan-Raj, C Bueso-Ramos, Y Takada, U Gaur, ...
Blood 109 (6), 2293-2302, 2007
|Natural products as a gold mine for arthritis treatment|
D Khanna, G Sethi, KS Ahn, MK Pandey, AB Kunnumakkara, B Sung, ...
Current opinion in pharmacology 7 (3), 344-351, 2007
|The multifaceted role of curcumin in cancer prevention and treatment|
MK Shanmugam, G Rane, MM Kanchi, F Arfuso, A Chinnathambi, ...
Molecules 20 (2), 2728-2769, 2015
|Exosome-mediated metastasis: from epithelial–mesenchymal transition to escape from immunosurveillance|
N Syn, L Wang, G Sethi, JP Thiery, BC Goh
Trends in pharmacological sciences 37 (7), 606-617, 2016
|Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways|
T Yi, SG Cho, Z Yi, X Pang, M Rodriguez, Y Wang, G Sethi, BB Aggarwal, ...
Molecular cancer therapeutics 7 (7), 1789-1796, 2008
|Dual role of autophagy in hallmarks of cancer|
SS Singh, S Vats, AYQ Chia, TZ Tan, S Deng, MS Ong, F Arfuso, CT Yap, ...
Oncogene 37 (9), 1142-1158, 2018
|Plumbagin (5-hydroxy-2-methyl-1, 4-naphthoquinone) suppresses NF-κB activation and NF-κB-regulated gene products through modulation of p65 and IκBα kinase activation, leading …|
SK Sandur, H Ichikawa, G Sethi, KS Ahn, BB Aggarwal
Journal of Biological Chemistry 281 (25), 17023-17033, 2006